Generative AI in Healthcare Market Trends

  • Report ID: 5728
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Generative AI in Healthcare Market Trends

Growth Drivers

  • The benefits of AI in terms of the economy- The application of AI in healthcare has a significant financial impact in terms of both revenue generation and cost reduction. AI-powered chatbots, for example, might offer patients and members quick, tailored assistance, reducing costly ER visits and enhancing access to preventative care. Predictive analytics helps medical practitioners take preventative measures and avoid later, more costly treatments by identifying individuals who are likely to develop chronic diseases. This year, more than half of healthcare organizations are getting ready to launch pilot programs to test out ChatGPT, an AI chatbot, for educational purposes. AI may also aid in population health management by enabling healthcare organizations to tailor their offerings to the needs of specific patients and member groups by identifying patterns and trends in enormous databases. AI in healthcare has the potential to improve patient care, save costs, and increase revenue overall.
  • Cooperation and technological developments- The generative AI in healthcare market is being pushed by partnerships between research organizations, healthcare facilities, and technology companies. These partnerships encourage the sharing of information, resources, and skills, expanding the potential uses of generative AI in healthcare. Furthermore, the development and sophistication of generative AI solutions are facilitated by improvements in computer capacity, data accessibility, and AI technology. AI in healthcare could result in savings of 5% to 10%. According to AI in healthcare data, 90% of nursing jobs will still be carried out by people in 2030.
  • The use of generative AI in drug repurposing is crucial- In drug repurposing, which involves re-evaluating already-approved medications for novel therapeutic indications by examining their molecular interactions, generative AI is essential. This method optimizes the use of already available pharmacological substances while also hastening the identification of possible remedies. Furthermore, generative AI is a priceless tool for improving clinical trial designs and forecasting patient reactions to different therapies, which boosts the effectiveness and success rates of medication development initiatives. By helping to identify patient subpopulations that are most likely to benefit from a specific medication, it helps to personalize treatment and lower the chance of unfavourable outcomes.

Challenges

  • Data dependability and quality- For training, generative AI models strongly depend on representative, varied, and high-quality datasets. Acquiring such information in the healthcare industry can be difficult because of problems including bias, fragmented data, and non-standard data formats. Applications' efficacy and security may be jeopardized by generative AI outputs that are imprecise or untrustworthy due to faulty or biased training data. thereby serving as a significant barrier to generative AI in healthcare market expansion.
  • Worries about the security and privacy of data.
  • Regulatory issues with AI use in healthcare.

Generative AI in Healthcare Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

32.4%

Base Year Market Size (2024)

USD 2.33 billion

Forecast Year Market Size (2037)

USD 89.52 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5728
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of generative AI in healthcare is assessed at USD 2.93 billion.

Generative AI in Healthcare Market size was valued at USD 2.33 billion in 2024 and is set to reach USD 89.52 billion by the end of 2037, registering around 32.4% CAGR during the forecast period i.e., between 2025-2037. The application of generative AI in medication research and development will drive the market growth.

North America industry is estimated to hold largest revenue share of 34% by 2037, impelled by cutting-edge AI technologies in the region.

The major players in the market are Oracle Corporation, NVIDIA Corporation, Google LLC, Epic Systems Corporation, Syntegra Medical Mind, Insilico Medicine, IBM Watson Health Corporation, Abridge AI Inc., DiagnaMed Holdings Corp., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample